Efficacy of the Use of Silver Diamine Fluoride and Sodium Fluoride Varnish for the Treatment of Caries in Children

Sponsor
Universidad Mayor de San Simón (Other)
Overall Status
Recruiting
CT.gov ID
NCT05638217
Collaborator
Universidad Privada del Valle, Sede Cochabamba (Other), Industria Química Farmacéutica SIGMA CORP S.R.L. Cochabamba, Bolivia (Other), NODK LLC, Oregón, EE. UU. (Other)
150
1
12.7
11.8

Study Details

Study Description

Brief Summary

The goal of this observational study is to identify the efficacy of silver diamine fluoride 38% followed by sodium fluoride varnish 5% in a population with untreated dental caries age range 4 to 12 years old. The main questions to answer are

  • Efficacy of treatment of active tooth decay with the treatment protocol of 38% silver diamine fluoride and 5% sodium fluoride varnish.

  • Clinical evaluation of tooth decay treated with 38% silver diamine fluoride and 5% sodium fluoride varnish in quality of hardness, color change and caries progression.

  • Explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with: i. Reduction of oral pain caused by the presence of carious lesions. ii. Improvement in gingival oral health. iii. Changes in general nutritional status through measurements of height, weight, hemoglobin levels and nutritional survey. The participants will be identified, charted (with nutritional surveys and parameters), as well as treated and compared in a six- and twelve-month period, where researchers will clinically identify the association between the use of this protocol and the efficacy of such, as well as other related nutritional aspects.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Silver diamine fluoride 38% followed by Sodium fluoride varnish 5%

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Cohort Study: Efficacy of the Use of 38% Silver Diamine Fluoride and 5% Sodium Fluoride Varnish in Patients 4 to 12 Years for the Treatment of Caries and Its Association With Other Aspects of Relevance
Actual Study Start Date :
Nov 7, 2022
Anticipated Primary Completion Date :
Nov 15, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients of 4 to 12 years old eligible to received dental cavity treatment

Patients of 4 to 12 years old that are eligible to received dental cavity treatment. The goal of this observational study is to identify the efficacy of silver diamine fluoride 38% followed by sodium fluoride varnish 5%, using "CaviGuard®" as delivery method, in a population with untreated dental caries age range 4 to 12 years old.

Combination Product: Silver diamine fluoride 38% followed by Sodium fluoride varnish 5%
1)Completely drying of the affected area 2)10 microliters of silver diamine fluoride 38% (CaviGuard®) will be placed on the affected area 3)The affected area should be immediately covered with 20 microliters of fluoride varnish 5% (CaviGuard®) 4)Repeat steps 1-3 one or two more times for large caries at intervals of at least 2 days apart 5)Follow up evaluation of treatment success visits will be conducted at 6 and 12 months from the initial treatment. NOTE: This is a single intervention using the device registered as Caviguard® to apply both products (Silver diamine fluoride 38% followed by Sodium fluoride varnish 5% (®)) in sequence.
Other Names:
  • CaviGuard®, Silver Diamine Fluoride (SDF)
  • Outcome Measures

    Primary Outcome Measures

    1. Ratio of arrested cavity lesions after treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish [6 months from initial treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions arrested after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist conducting an evaluation of multiple clinical findings including signs and symptoms of an active or arrested cavity.The clinical evaluation will be recorded in an odontograph for each patient.

    2. Ratio of arrested cavity lesions after treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish [12 months from treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist conducting an evaluation of multiple clinical findings including signs and symptoms of an active or arrested cavity.The clinical evaluation will be recorded in an odontograph for each patient.

    Secondary Outcome Measures

    1. Evaluate hardness [6 months from treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist, conducting an evaluation of clinical finding that include hardness. The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable hardness.

    2. Evaluate color change [6 months from treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist, conducting an evaluation of clinical finding that include color change.The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable color change.

    3. Evaluate cavity progression of cavity treated [6 months from treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist, conducting an evaluation of clinical finding that include cavity progression.The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable cavity progression.

    4. Evaluation the reduction of oral pain caused by the presence of carious lesions. [6 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the reduction of oral pain caused by the presence of carious lesions. The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable reduction of oral pain.

    5. Evaluate Improvement in gingival oral health. [6 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the Improvement in gingival oral health. The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable gingival oral health.

    6. Evaluate changes in height and weight [6 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the patient nutritional status through measurements of height and weight that will be combined with height and weight for age in child grow standards from the world health organization.

    7. Evaluate changes in hemoglobin levels [6 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the patient nutritional status through measurements of hemoglobin levels recorded as (g/dl).

    8. Evaluate changes in a nutritional survey [6 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the patient nutritional status through a 59 question nutritional survey developed by the research team.

    9. Evaluate hardness [12 months from initial treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist, conducting an evaluation of clinical finding that include hardness. The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable hardness.

    10. Evaluate color change [12 months from initial treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist, conducting an evaluation of clinical finding that include color change.The clinical evaluation will be recorded odontograph for each patient and include dichotomous variables (yes/no) for the variable color change.

    11. Evaluate cavity progression of cavity treated [12 months from initial treatment]

      The investigators will evaluate the efficacy of treatment of active cavity lesions after using the treatment protocol with 38% silver diamine fluoride and 5% sodium fluoride varnish. This evaluation will be performed by a trained dentist, conducting an evaluation of clinical finding that include cavity progression.The clinical evaluation will be recorded odontograph for each patient and include dichotomous variables (yes/no) for the variable cavity progression.

    12. Evaluation of the reduction of oral pain caused by the presence of carious lesions [12 months from initial treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the reduction of oral pain caused by the presence of carious lesions. The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable reduction of oral pain.

    13. Evaluate Improvement in gingival oral health. [12 months from initial treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the Improvement in gingival oral health. The clinical evaluation will be recorded in an odontograph for each patient and include dichotomous variables (yes/no) for the variable gingival oral health.

    14. Evaluate changes in height and weight [12 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the patient nutritional status through measurements of height and weight that will be combined with height and weight for age in child grow standards from the world health organization.

    15. Evaluate changes in hemoglobin levels [12 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the patient nutritional status through measurements of hemoglobin levels recorded as (g/dl).

    16. Evaluate changes in a nutritional survey [12 months from treatment]

      The investigators will explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with the patient nutritional status through a 59 question nutritional survey developed by the research team.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • The patient must be able to receive all necessary treatments and may be followed up for additional treatments and/or record follow-ups at each time point and for the duration of the study.

    • Children within the age range mentioned above.

    • Require a completed informed consent form and completed nutritional survey record for anyone who will participate in the program.

    • According to the evaluation of the dentist Caries grade I and grade II

    • In the case of patients with disabilities, at least one parent or legal guardian must be present at all times during the study.

    Exclusion Criteria:
    • Patients who, after assessment, identify a pulp condition or abscess in any of the teeth, this affected piece will be excluded from receiving treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish (in these cases, the Patient Coordinator will refer to a dentist outside the study for their treatment)

    • Patients with caries with grade III or grade IV

    • Patients with a known allergy to any of the active ingredients ( 38% silver diamine fluoride and 5% sodium fluoride varnish)

    • Patients who were unable to give their informed consent or complete the nutritional survey.

    • Patients who cannot participate during the entire program (12 months).

    • Patients with other oral treatments (Orthodontics).

    • Patients who are not present with at least one parent or legal guardian at the time of treatment.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Bolivian Food Bank Foundation Cochabamba Bolivia 00000

    Sponsors and Collaborators

    • Universidad Mayor de San Simón
    • Universidad Privada del Valle, Sede Cochabamba
    • Industria Química Farmacéutica SIGMA CORP S.R.L. Cochabamba, Bolivia
    • NODK LLC, Oregón, EE. UU.

    Investigators

    • Principal Investigator: Nathaly Campero Ferrufino, DDS, Private University of the Valley
    • Principal Investigator: Ximena Claros Martinez, DDS, Private University of the Valley
    • Principal Investigator: Edwin Guarayo Molina, DDS, Private University of the Valley
    • Principal Investigator: Rodrigo k Arce Cardozo, MD, MPH,, Universidad Mayor de San Simon
    • Principal Investigator: Steve Duffin, DDS, NODK LLC

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Rodrigo Arce Cardozo, Associate Research Professor, Universidad Mayor de San Simón
    ClinicalTrials.gov Identifier:
    NCT05638217
    Other Study ID Numbers:
    • DINV-CAV01-EC001
    First Posted:
    Dec 6, 2022
    Last Update Posted:
    Dec 6, 2022
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rodrigo Arce Cardozo, Associate Research Professor, Universidad Mayor de San Simón
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 6, 2022